enhance in Medical Technology

Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin

Identifies potential clinical trial strategies for personalized approach to cancer treatment SEATTLE, April 21 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC), presented data from a preclinical study, whic...

Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts

ANNAPOLIS, Md., Aug. 20 /PRNewswire/ -- Do you currently have a study that is falling behind with recruitment? Have you given your sites recruitment tools and a budget for media but still have not seen the desired results? Perhaps what you need is an extra set of hands to help your sites navig...

Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments

- Randomized Phase II data show RAD001 significantly increased efficacy of letrozole tablets in women with newly diagnosed hormone-positive breast cancer - Phase I studies suggest RAD001 may help overcome a major pathway of resistance to ...

UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials

Leading CNS experts collaborate with UBC to provide best science available BETHESDA, Md., March 25 /PRNewswire/ -- To offer clients cutting-edge thinking in study methodology for CNS clinical trials, United BioSource Corporation (UBC) announces the formation of a European Advisory Board for Dat...

Physicians Reconsider Implications of Enhance Trial

First Impact Report Reveals Shift in Prescribing Patterns As More MDs Question Clinical Outcomes of Cholesterol-Reducing Drug NEW YORK, Feb. 7 /PRNewswire/ -- Despite the controversy surrounding the release of the preliminary ENHANCE trial results on January 14, 2008, physicians are le...

ReachMD Broadcasts First-of-its-Kind Physician Peer-Peer Discussion on ENHANCE Trial

Renowned cardiologists participate in controversial debate over effects of Simvastatin vs. Ezetimibe/Simvastatin CHICAGO, Feb. 4 /PRNewswire/ -- ReachMD, an innovative multi-channel platform for medical professionals, will air on XM Satellite Radio Channel 157 and simulcast via ...

Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures

Study of more than 2,500 patients shows marked improvement of skin texture, color and overall appearance SAN ANTONIO, Feb. 1 /PRNewswire-FirstCall/ -- Obagi Medical Products, Inc. (Nasdaq: OMPI ), a leader in topical aesthetic and therapeutic skin health systems, announced ...

CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals

VIENNA, Va., May 01, 2007 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION announces that CEL-1000 alone increased the immune response against hepatitis B antigen, and that the combination of CEL-1000 with MAS-1, a proprietary water-in-oil adjuvant delivery system owned by Mercia Pharma, induced high...

CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals

VIENNA, Va., May 23, 2007 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION announces that CEL-1000 increased the immune response against H5 avian influenza antigen in combination with MAS-1, a water-in-oil adjuvant delivery system. These findings were presented on May 23, 2007 by Dr. Daniel Zimmerman...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...tereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventio...

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

..., ARUP chooses instead to support clients' existing test menus by offering highly complex and unique tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services. ARUP's clients include more than half of the nation's university teaching hospitals...

Study Shows Brain Fitness can Save Medicare Billions

...how that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention and enhance quality of life. Posit Science has received grants from the National Institutes of Health and numerous awards and accolades. The company's products, s...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

...ooking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software products to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business stra...

FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents

...ceptors is thought to strengthen working memory, reduce susceptibility to distraction, improve attention regulation, improve behavioral inhibition and enhance impulse control.(6-10) Although the mechanism of action of guanfacine in the treatment of ADHD is not fully understood, preclinical research suggests ...

UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201

...s closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the ava...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

...anization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

...anization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

...anization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

...out the opportunity to expand our portfolio in bladder cancer treatment and enhance our late stage development pipeline," said David Holveck, president and chi...cessful in clinical development, Urocidin has the potential to extend and enhance our recent therapeutic expansion and strengthen the Valstar franchise." ...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

...am use with FDA approval and CMS reimbursement. The MARVEL II program aims to streamline both screening and follow-up to facilitate enrollment and to enhance safety monitoring. During the panel discussion, Dr. Christopher O'Connor, Director Heart Center, Duke University Medical Center commented on th...

New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF

... individual treatments.[2] HP-hMG and rFSH are two commonly used hormonal therapies belonging to the class of drugs known as gonadotropins that enhance egg production in IVF treatment. HP-hMG, contains both FSH and hCG-driven (human chorionic gonadotropin) LH-activity (luteinizing hormone). In contras...

AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain

...ns where there is an unmet need for improved safety and efficacy. The company applies its proprietary NanoTab dosage form and delivery technologies to enhance the safety, therapeutic benefit and commercial attractiveness of currently approved compounds. For additional information about AcelRx Pharmaceuticals...

Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative

...are appointments for urgent needs. After-hours urgent care and telephonic nurse advice tied to EHR. Direct access to specialists. Group visits enhance educational opportunities and build social support among patients with common health needs. Telephone visits and secure messaging with the car...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

...sing well for initiating a therapeutic vaccination study in people already infected with HIV/AIDS. We are also utilizing our $17 million NIH grant to enhance our vaccine development." Dr. McNally added, "We also are greatly encouraged by our recently signed proposal to discuss a cooperative arrangemen...

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

..., a leading biopharmaceutical company, is building a diversified portfolio of oncology products that represents a comprehensive approach to extend and enhance the lives of patients with cancer. Cephalon Oncology is a strategic business unit focused on the development and commercialization of oncology product...

Brain Fitness Makes Boomers Age Younger

...ow that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention, and enhance quality of life. Posit Science has received grants from the National Institutes of Health and numerous awards and accolades. The company's products, s...

Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy

...e painless, non-invasive solution offers an ideal alternative to surgery-averse patients. Pollogen is dedicated to continuing to develop products that enhance the wellbeing of patients worldwide" commented Dr. Zion Azar Pollogen's Chairman and CEO. About Pollogen: Pollogen Ltd. develops, manufa...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

... Multi-Center, Randomized Trial to Test Unique Delivery System Using Living Cells to enhance Wound Healing Marks Milestone for Fort Worth, Texas-based Specialty Biopharmaceutical Company FORT WORTH, Texas, June 16 /PRNewswire/ -- HEAL...

Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association

...developed in collaboration with Genentech, Inc. for the treatment of autoimmune indications; and two pre-clinical candidates, TRX518 and TRX385, that enhance immune responses and are being evaluated for potential benefit in the treatment of cancer, chronic viral diseases, and as vaccine adjuvants. Tolerx is...

Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival

...s in the industry, BSI-201 is the furthest along in clinical development in metastatic TNBC. BSI-201 is currently being evaluated for its potential to enhance the effect of chemotherapy-induced DNA damage. The clinical development of BSI-201 is supported by well documented safety profile based on studies of ...

Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer

...ic insertion of feeding tubes. Published preclinical studies have demonstrated that, unlike standard paclitaxel and other chemotherapeutic agents that enhance radiation killing by a factor of 1.5 to 2.0, OPAXIO increases tumor specific radiation cell kill by a factor of 7.2 to 8.4 -fold (Milas Luka et al , P...

CuraGen Updates CR011-vcMMAE Data at ASCO

...d the breast cancer opportunity and to understand how dose, schedule and the use of biomarkers such as the presence of GPNMB and rash might be used to enhance activity in further development." Reprints of the presentation are available on CuraGen's website at http://www.curagen.com or can be reque...

Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting

...ortunities originating in China. HUYA has established extensive collaborations with Chinese academic and commercial biopharmaceutical organizations to enhance development efficiency and value creation in worldwide markets for China-sourced product candidates. With the largest Chinese compound portfolio cover...

Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease

...heir commitment to advance this test for Alzheimer's disease," said Ron Zwanziger, CEO of Inverness. "This is an exciting opportunity for Inverness to enhance the lives of patients with chronic disease and continues our commitment to rapidly deploy diagnostics and develop new treatments for devastating disea...

Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy

...he ongoing Phase II clinical trial, has yielded valuable insights for the entire gene therapy field, dispelling many myths and revealing strategies to enhance vector uptake in humans with numerous applications." While conventional drug therapies have improved survival of patients with congestive heart f...

TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009

... Session Type: Poster Discussion Abstract Number: 3518 TRC102 Abstract Title: A Phase 1 study of daily oral TRC102 (methoxyamine) to enhance the therapeutic effects of pemetrexed in patients with advanced refractory cancer Presenter: Steven Anthony, DO, Evergreen Hematology and Onco...

Senesco Announces H1N1 Influenza Survival Test Results in Mice

...g-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products. Certain statements included in this press release are forward-looking statements within the meaning of the Private Sec...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

...lying traditional breeding tools, as well as modern plant molecular biology tools, to improve plant yield, oil quality, fertilizer requirements and to enhance stress and disease tolerance. ACGT and SGI have also been exploring the microbial life around the jatropha tree using environmental genomic tec...

Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients

... Suggests additional training to help brain adapt more fully and further enhance benefits BOSTON, May 19 /PRNewswire-USNewswire/ -- In a study of spec...r the prisms, which means that improved training in their use could further enhance the benefits, says principal investigator, Dr. Eli Peli, a senior scientist...

Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

...f diazoxide - including DCCR - as well as pharmaceutical formulations of such salts. Additional applications filed in the US and globally will further enhance the patent portfolio of Essentialis. Commenting on these developments, Essentialis President and CEO, Dr Iain Dukes said, "Essentialis has convin...